Gyre Therapeutics, Inc. (GYRE) › Gross ProfitGyre Therapeutics, Inc. (GYRE): Gross ProfitAnnual figures by period end, from SEC filings.$101.87MYear ended 2024-12-31$108.81M2022-12-31: $97.50M2023-12-31: $108.81M2024-12-31: $101.87M$101.87M2022-12-31 Gross Profit (USD) 2024-12-31Period endedGross ProfitChange YoYSource filing2024-12-31$101.87M-6.4%2025-03-17, From 2024-01-012023-12-31$108.81M+11.6%2025-03-17, From 2023-01-012022-12-31$97.50Mn/a2024-03-27, From 2022-01-01Other metrics: RevenueCost of RevenueR&D ExpenseOperating IncomeDepreciation & AmortizationEBITDANet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesLong-Term DebtShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)